- Home
- ABSI vs SENS Comparison
ABSI vs SENS Comparison
Compare ABSI & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABSI
- SENS
- Stock Information
- Founded
- ABSI 2011
- SENS 1996
- Country
- ABSI United States
- SENS United States
- Employees
- ABSI N/A
- SENS N/A
- Industry
- ABSI Biotechnology: Pharmaceutical Preparations
- SENS Industrial Machinery/Components
- Sector
- ABSI Health Care
- SENS Industrials
- Exchange
- ABSI Nasdaq
- SENS Nasdaq
- Market Cap
- ABSI 353.8M
- SENS 392.5M
- IPO Year
- ABSI 2021
- SENS N/A
- Fundamental
- Price
- ABSI $2.75
- SENS $0.63
- Analyst Decision
- ABSI Strong Buy
- SENS Strong Buy
- Analyst Count
- ABSI 5
- SENS 2
- Target Price
- ABSI $8.40
- SENS $2.00
- AVG Volume (30 Days)
- ABSI 2.5M
- SENS 3.1M
- Earning Date
- ABSI 05-13-2025
- SENS 05-08-2025
- Dividend Yield
- ABSI N/A
- SENS N/A
- EPS Growth
- ABSI N/A
- SENS N/A
- EPS
- ABSI N/A
- SENS N/A
- Revenue
- ABSI $4,534,000.00
- SENS $23,682,000.00
- Revenue This Year
- ABSI $158.58
- SENS $60.14
- Revenue Next Year
- ABSI $93.12
- SENS $36.55
- P/E Ratio
- ABSI N/A
- SENS N/A
- Revenue Growth
- ABSI N/A
- SENS 1.64
- 52 Week Low
- ABSI $2.01
- SENS $0.25
- 52 Week High
- ABSI $6.33
- SENS $1.40
- Technical
- Relative Strength Index (RSI)
- ABSI 42.92
- SENS 43.79
- Support Level
- ABSI $2.85
- SENS $0.65
- Resistance Level
- ABSI $2.94
- SENS $0.75
- Average True Range (ATR)
- ABSI 0.19
- SENS 0.05
- MACD
- ABSI -0.03
- SENS -0.00
- Stochastic Oscillator
- ABSI 14.13
- SENS 4.91
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.